CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,390,523 | -10.9% | 184,854 | +10.3% | 0.02% | -10.0% |
| Q2 2023 | $9,412,922 | +21.6% | 167,596 | -2.1% | 0.02% | +11.1% |
| Q1 2023 | $7,741,882 | +16.4% | 171,167 | +4.6% | 0.02% | +5.9% |
| Q4 2022 | $6,650,422 | -39.7% | 163,602 | -3.1% | 0.02% | -43.3% |
| Q3 2022 | $11,029,000 | +22.7% | 168,775 | +14.1% | 0.03% | +30.4% |
| Q2 2022 | $8,991,000 | -32.0% | 147,946 | -29.8% | 0.02% | +64.3% |
| Q1 2022 | $13,230,000 | +40.3% | 210,764 | +69.3% | 0.01% | -30.0% |
| Q4 2021 | $9,432,000 | -4.9% | 124,477 | +40.4% | 0.02% | -20.0% |
| Q3 2021 | $9,923,000 | -14.3% | 88,648 | +23.9% | 0.02% | -21.9% |
| Q2 2021 | $11,580,000 | +33.0% | 71,529 | +0.1% | 0.03% | +6.7% |
| Q1 2021 | $8,710,000 | +44.2% | 71,482 | +81.1% | 0.03% | +36.4% |
| Q4 2020 | $6,042,000 | +84.8% | 39,467 | +1.0% | 0.02% | +37.5% |
| Q3 2020 | $3,269,000 | +67.4% | 39,086 | +47.1% | 0.02% | +33.3% |
| Q2 2020 | $1,953,000 | +275.6% | 26,580 | +116.6% | 0.01% | +200.0% |
| Q1 2020 | $520,000 | -22.0% | 12,271 | +12.0% | 0.00% | 0.0% |
| Q4 2019 | $667,000 | +75.5% | 10,954 | +18.2% | 0.00% | +33.3% |
| Q3 2019 | $380,000 | – | 9,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |